Adage is a dirty word to me as well as many in Adxs. In 2015 we all thought different but they`ve shown their stripes. They fleeced this company and shareholders,and I for one wish they`d sell. I`m sure Edelman and friends would be willing to buy their shares. They killed us IMO,but I can`t prove it,and that`s why they got away with it. Adxs seemed to help them completely with TL in charge for a year,but at least that crud`s behind us now and Ken looks like a real leader with some chops,so I`m hoping he can remedy the Adage situation with a deal for Axal and PSA. I`m not a believer that dilution at a buck is n our cards now,IMO,we cleared that hurdle by hiring Ken,because I`m confident he`ll deliver the deals that we need. Merck`s not gonna throw away 2 free trials,and good data,so the warning shot`s been fired,and if they snooze they lose. Adxs loses too,but IMO,the PSA HOT will be better,and that`s why I thought Ken should include first right of refusal for a HOT app for PSA,with the PSA axal deal,and the same logic for Cervix if a HOT app can be used for that as well. It`s deal time,,so let`s send out positive vibes for Ken and the crew at Adxs to see..
News 
Market Data 
Discover 
AI
